Back

Diagnosis rate and treatment pattern of chronic kidney disease in cardiovascular disease population: a national cross-sectional study in China

31 August 2025 (08:35 - 08:45)
Organised by: Logo
Congress Presentation Part of: The cardio-kidney disease link Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Yihang Ling

Guangdong Provincial People's Hospital, Guangzhou (China)

5 More presentations in this session

Presentation thumbnail
The effect of dialysis type on right ventricular function and patient outcomes in end-stage renal disease
Professor S. Sung (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Comparing the efficacy and safety of DOACs with VKAs in patients with end-stage kidney disease on dialysis and non-valvular atrial fibrillation: a systematic review and meta-analysis
Doctor T. Li (Freiburg, DE)
Abstract Slides Video
Presentation thumbnail
Preoperative baseline troponin as a predictor of major adverse cardiac events following kidney transplantation in patients with end-stage kidney disease
Doctor K. Ramanathan (Vancouver, CA)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of percutaneous coronary intervention in NSTEMI patients with different stages of chronic kidney disease: a multi-center retrospective study
Doctor J. Liu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
A prospective controlled study of the effects of renal transplantation on uraemic cardiomyopathy using cardiac magnetic resonance imaging
Professor J. Townend (Birmingham, GB)
Abstract Slides Video

Access the full session

Session thumbnail
The cardio-kidney disease link
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 08:35 CET
You may be interested in
thumbnail
Congress Presentation
Kidney function and coronary artery disease
thumbnail
Congress Session
The cardio-kidney disease link
thumbnail
Congress Session
Caring for kidney disease patients in a cardiology setting: what is important?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources